rs148951753

Variant summary

Our verdict is Benign. The variant received -17 ACMG points: 0P and 17B. BP4BP6_Very_StrongBS1BS2

The NM_004484.4(GPC3):​c.889A>G​(p.Arg297Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000266 in 1,209,352 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 95 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R297K) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.00019 ( 0 hom., 5 hem., cov: 23)
Exomes 𝑓: 0.00027 ( 0 hom. 90 hem. )

Consequence

GPC3
NM_004484.4 missense

Scores

1
6
10

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.941

Publications

1 publications found
Variant links:
Genes affected
GPC3 (HGNC:4451): (glypican 3) Cell surface heparan sulfate proteoglycans are composed of a membrane-associated protein core substituted with a variable number of heparan sulfate chains. Members of the glypican-related integral membrane proteoglycan family (GRIPS) contain a core protein anchored to the cytoplasmic membrane via a glycosyl phosphatidylinositol linkage. These proteins may play a role in the control of cell division and growth regulation. The protein encoded by this gene can bind to and inhibit the dipeptidyl peptidase activity of CD26, and it can induce apoptosis in certain cell types. Deletion mutations in this gene are associated with Simpson-Golabi-Behmel syndrome, also known as Simpson dysmorphia syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Sep 2009]
GPC3 Gene-Disease associations (from GenCC):
  • Simpson-Golabi-Behmel syndrome
    Inheritance: XL Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • Simpson-Golabi-Behmel syndrome type 1
    Inheritance: XL Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, G2P, Labcorp Genetics (formerly Invitae)

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_004484.4, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -17 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.28073817).
BP6
Variant X-133753625-T-C is Benign according to our data. Variant chrX-133753625-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 415278.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000187 (21/112276) while in subpopulation NFE AF = 0.000357 (19/53245). AF 95% confidence interval is 0.000233. There are 0 homozygotes in GnomAd4. There are 5 alleles in the male GnomAd4 subpopulation. Median coverage is 23. This position passed quality control check.
BS2
High Hemizygotes in GnomAd4 at 5 XL gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_004484.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GPC3
NM_004484.4
MANE Select
c.889A>Gp.Arg297Gly
missense
Exon 3 of 8NP_004475.1I6QTG3
GPC3
NM_001164617.2
c.889A>Gp.Arg297Gly
missense
Exon 3 of 9NP_001158089.1P51654-3
GPC3
NM_001164618.2
c.841A>Gp.Arg281Gly
missense
Exon 3 of 8NP_001158090.1B4DTD8

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
GPC3
ENST00000370818.8
TSL:1 MANE Select
c.889A>Gp.Arg297Gly
missense
Exon 3 of 8ENSP00000359854.3P51654-1
GPC3
ENST00000394299.7
TSL:1
c.889A>Gp.Arg297Gly
missense
Exon 3 of 9ENSP00000377836.2P51654-3
GPC3
ENST00000631057.2
TSL:1
c.727A>Gp.Arg243Gly
missense
Exon 2 of 7ENSP00000486325.1P51654-2

Frequencies

GnomAD3 genomes
AF:
0.000187
AC:
21
AN:
112223
Hom.:
0
Cov.:
23
show subpopulations
Gnomad AFR
AF:
0.0000648
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000357
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000207
AC:
38
AN:
183321
AF XY:
0.000133
show subpopulations
Gnomad AFR exome
AF:
0.0000760
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000452
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000274
AC:
301
AN:
1097076
Hom.:
0
Cov.:
32
AF XY:
0.000248
AC XY:
90
AN XY:
362454
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26380
American (AMR)
AF:
0.00
AC:
0
AN:
35206
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
19377
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30203
South Asian (SAS)
AF:
0.00
AC:
0
AN:
54116
European-Finnish (FIN)
AF:
0.0000987
AC:
4
AN:
40527
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4134
European-Non Finnish (NFE)
AF:
0.000342
AC:
288
AN:
841074
Other (OTH)
AF:
0.000195
AC:
9
AN:
46059
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.485
Heterozygous variant carriers
0
12
25
37
50
62
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000187
AC:
21
AN:
112276
Hom.:
0
Cov.:
23
AF XY:
0.000145
AC XY:
5
AN XY:
34440
show subpopulations
African (AFR)
AF:
0.0000647
AC:
2
AN:
30931
American (AMR)
AF:
0.00
AC:
0
AN:
10597
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
2650
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3569
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2655
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
6189
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
218
European-Non Finnish (NFE)
AF:
0.000357
AC:
19
AN:
53245
Other (OTH)
AF:
0.00
AC:
0
AN:
1537
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1
2
4
5
6
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000192
Hom.:
8
Bravo
AF:
0.000159
EpiCase
AF:
0.000273
EpiControl
AF:
0.000178

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
1
not specified (1)
-
-
1
Wilms tumor 1 (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
-0.22
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
21
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.53
D
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.90
D
M_CAP
Benign
0.023
T
MetaRNN
Benign
0.28
T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
1.9
L
PhyloP100
0.94
PrimateAI
Uncertain
0.50
T
PROVEAN
Pathogenic
-4.6
D
REVEL
Benign
0.25
Sift
Benign
0.099
T
Sift4G
Uncertain
0.019
D
PromoterAI
-0.0072
Neutral
Varity_R
0.63
gMVP
0.63
Mutation Taster
=94/6
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs148951753;
hg19: chrX-132887652;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.